Overview

To Assess the Bioequivalence of the 4mg Prototype Mini Nicotine Lozenge to the Reference Product (Nicorette) in Healthy Smokers

Status:
Completed

Trial end date:
2018-11-12

Target enrollment:

Participant gender:

Summary

This study will assess the bioequivalence of the test product (Nicotine Prototype Mini lozenge 4 milligrams [mg]) to a commercial reference product (nicotine polacrilex mini lozenge 4mg) in healthy smokers under fasting conditions.

Phase:

Phase 1

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Nicotine